The guanine nucleoside analog penciclovir is active against chronic duck hepatitis B virus infection in vivo

Antimicrobial Agents and Chemotherapy

Volumn 40, Issue 2, 1996, Pages 413-418

  Lin, Enjarn ^a   Luscombe, Carolyn ^a,b   Wang, Yan Yan ^a   Shaw, Tim ^a   Locarnini, Stephen ^a  

^a FAIRFIELD HOSPITAL   (Australia)

^b UNIVERSITY OF NEW MEXICO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GUANOSINE DERIVATIVE; HEPATITIS B ANTIGEN; PENCICLOVIR;

ANIMAL MODEL; ANIMAL TISSUE; ANTIVIRAL ACTIVITY; ARTICLE; CONGENITAL INFECTION; CONTROLLED STUDY; DNA HYBRIDIZATION; DNA SYNTHESIS INHIBITION; FEMALE; HEPATITIS B; HEPATITIS B VIRUS; INTRAPERITONEAL DRUG ADMINISTRATION; LIVER; NONHUMAN; PRIORITY JOURNAL; PROTEIN SYNTHESIS INHIBITION; VIREMIA; VIRUS INHIBITION;

EID: 0030061124     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/aac.40.2.413     Document Type: Article

References (38)

1. Bishop, N., G. Civitico, Y. Wang, K. Guo, C. Birch, I. Gust, and S. Locarnini. 1990. Antiviral strategies in chronic hepatitis B virus infection. I. Establishment of an in vitro system using the duck hepatitis B virus model J. Med. Virol. 31:82-89.
2. Civitico, G., and S. Locarnini. 1994. The half-life of duck hepatitis B virus supercoiled DNA in congenitally infected primary hepatocyte cultures. Virology 203:81-89.
3. Dean, J., S. Bowden, and S. Locarnini. 1994. Reversion of duck hepatitis B virus DNA replication in vivo following cessation of treatment with the nucleoside analogue ganciclovir. Antivir. Res. 27:171-178.
4. Fourel, I., J. Saputelli, P. Schaffer, and W. S. Mason. 1994. The carbocyclic analogue of 2′-deoxyguanosine induces a prolonged inhibition of duck hepatitis B virus DNA synthesis in primary hepatocyte cultures and in the liver. J. Virol. 68:1059-1065.
5. Heringa, J., and P. Argos. 1994 Evolution of viruses as recorded by their polymerase sequences In S S Morse (ed.), The evolutionary biology of viruses. Raven Press, New York.
6. Ilsley, D. D., S.-H. Lee, W. H. Miller, and R. D. Kuchta. 1995. Acyclic guanosine analogs inhibit DNA polymerases α, δ and ε with very different potencies and have unique mechanisms of action. Biochemistry 34:2504-2510.
7. Jilbert, A., J. Freiman, C. Burrell, M. Holmes, E. Gowans, R. Roweand, P. Hall, and Y. Cossart. 1988 Virus-liver cell interactions in duck hepatitis B virus infection: a study of virus dissemination within the liver. Gastroenterology 95:1375-1382.
8. Kejian, G., and D. S. Bowden. 1991. Digoxigenin-labeled probes for the detection of hepatitis B virus DNA in serum J. Clin. Microbiol. 29:506-509.
9. Keller, P., S. McKee, and J. Fyfe. 1985. Cytoplasmic 5′-nucleotidase catalyses acyclovir phosphorylation. J. Biol. Chem. 260:8664-8667.
10. Kurstak, E. (ed.). 1992. Viral hepatitis: current status and issues. Springer-Verlag, New York.
11. Lee, B., W. Luo, S. Suzuki, M. J. Robins, and D. Tyrrell. 1989. In vitro and in vivo comparison of the abilities of purine and pyrimidine 2′,3′-dideoxynucleosides to inhibit duck hepadnavirus. Antimicrob. Agents Chemother. 33:336-339.
12. Lenhoff, R. J., and J. Summers. 1994. Coordinate regulation of replication and virus assembly by the large envelope protein of an avian hepadnavirus. J. Virol. 68:4565-1571.
13. Lenhoff, R. J., and J. Summers. 1994. Construction of avian hepadnavirus variants with enhanced replication and cytopathicity in primary hepatocytes. J. Virol. 68:5706-5713
14. Littler, E., A. Stuart, and M. Chee. 1992 Human cytomegalovirus UL97 open reading frame encodes a protein that phosphorylates the antiviral nucleoside ganciclovir. Nature (London) 358:160-162.
15. Lok, A. 1994 Treatment of chronic hepatitis B. J. Vir. Hepatitis 1:105-124.
16. Luscombe, C., J. Pedersen, S. Bowden, and S. Locarnini. 1994. Alterations in intrahepatic expression of duck hepatitis B viral markers with ganciclovir chemotherapy. Liver 14:182-192.
17. Mason, W., J. Cullen, J. Saputelli, T.-T. Wu, C. Liu, W. London, E. Lustbader, P. Schaffer, A. O'Connell, I. Fourel, C. Aldrich, and A. Jilbert. 1994. Characterisation of the antiviral effects of 2′-carbodeoxyguanosine in ducks congenitally infected with duck hepatitis B virus. Hepatology 19:398-411.
18. Mason, W., M. Halpern, J. England, G. Seal, J. Egan, L. Coates, C. Aldrich, and J. Summers. 1983. Experimental transmission of duck hepatitis B virus. Virology 131:375-384
19. Mason, W. S., G. Seal, and J. Summers. 1980 Virus of Pekin ducks with structural and biological relatedness to human hepatitis B virus. J. Virol. 36: 829-836.
20. Mok, S. S., T. Shaw, and S. Locarnini. 1995. Preferential inhibition of human hepatitis B virus (HBV) polymerase by the (R)-enantiomer of penciclovir triphosphate, abstr. H66, p 191 In Program and abstracts of the 35th Interscience Conference on Antimicrobial Agents and Chemotherapy American Society for Microbiology, Washington, D.C.
21. Newbold, J. E., H. Xin, M. Teneza, G. Sherman, J. Dean, S. Bowden, and S. Locarnini. 1995 The covalently closed duplex form of the hepadnavirus genome exists in situ as a heterogeneous population of viral minichromosomes. J. Virol. 69:3350-3357
22. Niu, J., Y. Wang, R. Dixon, S. Bowden, M. Qiao, L. Einck, and S. Locarnini. 1993 The use of ampligen alone and in combination with ganciclovir and coumermycin A1 for the treatment of ducks congenitally-infected with duck hepatitis B virus. Antivir. Res. 21:155-171.
23. Price, P. M., R. Banerjee, A. M. Jeffrey, and G. Aes. 1992. The mechanism of inhibition of hepatitis B virus replication by the carbocyclic analog of 2′-deoxyguanosine Hepatology 16:8-12.
24. Saltzman, R., R. Jurewicz, and R. Boon. 1994. Safety of famciclovir in patients with herpes zoster and genital herpes. Antimicrob. Agents Chemother. 38:2454-2457
25. Shaw, T., P. Amor, G. Civitico, M. Boyd, and S. Locarnini. 1994 In vitro antiviral activity of penciclovir, a novel purine nucleoside, against duck hepatitis B virus Antimicrob Agents Chemother. 38:719-723.
26. Shaw, T., and S. Locarnini. 1995 Hepatic purine and pyrimidine metabolism, implications for antiviral chemotherapy in viral hepatitis. Liver 15:169-184
27. Sherker, A., and P. Marion. 1991. Hepadnaviruses and hepatocellular car cinoma. Annu. Rev. Miciobiol 45:475-508.
28. Sullivan, V., C. Talarico, S. Stanat, M. Davis, D. Coen, and K. Biron. 1992. A protein kinase homologue controls phosphorylation of ganciclovir of cytomegalovirus infected cells. Nature (London) 358:162-164
29. Summers, J., and W. Mason. 1982. Replication of the genome of a hepatitis B-like virus by reverse transcription of an RNA intermediate Cell 29:403-415.
30. Summers, J., P. M. Smith, M. Huang, and M. Yu. 1991. Morphogenetic and regulatory mutations in the envelope proteins of an avian hepadnavirus J Virol. 65:1310-1317
31. Tsiquaye, K. N., M. J. Slomka, and M. Muang. 1994. Oral famciclovir against hepatitis B virus replication in hepatic and nonhepatic tissues of ducklings infected in ovo. J. Med. Virol. 42:306-310.
32. Tuttleman, J., C. Pourcel, and J. Summers. 1986. Formation of the pool of covalently closed circular viral DNA in hepadnavirus-infected cells. Cell 47: 451-450.
33. Vere Hodge, R. 1993. Famciclovir and penciclovir. The mode of action of famciclovir including its conversion to penciclovir. Antivir. Chem. Chemother. 4:67-84.
34. Wang, Y., S. Bowden, T. Shaw, G. Civitico, M. Qiao, and S. Locarnini. 1991. Inhibition of duck hepatitis B virus replication in vivo by the nucleoside analogue ganciclovir (9-[2-hydroxy-1-(hydroxymethyl) ethoxymethyl] guanine) Antivir. Chem. Chemother. 2:107-114
35. Wang, Y., C. Luscombe, S. Bowden, T. Shaw, and S. Locarnini. 1995. Inhibition of duck hepatitis B virus DNA replication by antiviral chemotherapy with ganciclovir-nalidixic acid. Antimicrob. Agents Chemother. 39:556-558.
36. Yokosuka, O., M. Omata, F. Imazeki, K. Okuda, and J. Summers. 1985. Changes of hepatitis B virus DNA in liver and serum caused by recombinant leukocyte interferon treatment: analysis of intrahepatic replicative hepatitis B virus DNA. Hepatology 5:728-734.
37. Zoulim, F., E. Dannaoui, and C. Trepo. 1995. Inhibitory effect of penciclovir on the priming of hepadnavirus reverse transcription, abstr H13, p. 182 In Program and abstracts of the 35th Interscience Conference on Antimicrobial Agents and Chemotherapy American Society for Microbiology, Washington, D.C.
38. Zoulim, F., and C. Seeger. 1994. Reverse transcription in hepatitis B viruses is primed by a tyrosine residue of the polymerase. J. Virol 68:6-13